+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

Benign Prostatic Hyperplasia- Market Insight, Competitive Landscape and Market Forecast, 2027 - Product Thumbnail Image

Benign Prostatic Hyperplasia- Market Insight, Competitive Landscape and Market Forecast, 2027

  • Report
  • July 2022
  • 100 Pages
  • Global
From
Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 160 Pages
  • Global
From
Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Benign prostatic hyperplasia (BPH) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Benign prostatic hyperplasia (BPH) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Prostate Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Prostate Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Castration-Sensitive Prostate Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Prostate Cancer Treatment Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, End Users, and Geography - Product Thumbnail Image

Prostate Cancer Treatment Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, End Users, and Geography

  • Report
  • March 2024
  • 150 Pages
  • Global
From
Prostate Cancer Therapeutics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type, End User, and Geography - Product Thumbnail Image

Prostate Cancer Therapeutics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type, End User, and Geography

  • Report
  • December 2023
  • 150 Pages
  • Global
From
Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2024-2028 - Product Thumbnail Image

Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2024-2028

  • Report
  • December 2023
  • 160 Pages
  • Global
From
Benign prostatic hyperplasia (BPH) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Benign prostatic hyperplasia (BPH) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hormone Sensitive Advanced Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Hormone Sensitive Advanced Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hot Flashes in Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Hot Flashes in Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Castrate-Sensitive Prostate Cancer (CSPC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Castrate-Sensitive Prostate Cancer (CSPC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Neuroendocrine Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Castrate-Resistant Prostate Cancer (CRPC)- Epidemiology Forecast to 2032 - Product Thumbnail Image

Castrate-Resistant Prostate Cancer (CRPC)- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more